Cornell University professor James Antaki's $6.7 million grant for his life-saving infant heart device, PediaFlow, was unexpectedly revoked by the Department of Defense. The grant, intended for production and testing, was rescinded without explanation, jeopardizing three decades of research. Antaki, facing potential layoffs and research project termination, is appealing for the funding's reinstatement. The decision impacts children born with heart defects, for whom PediaFlow offers a vital treatment option, currently lacking in commercially available solutions. The lack of explanation from the Defense Department or White House adds to the uncertainty surrounding this crucial medical advancement.

Prepared by Olivia Bennett and reviewed by editorial team.